ICD-10-CM Billable Code

N85.2

Hypertrophy of uterus

Clinical Classification Guidelines

Inclusion Terms

  • Bulky or enlarged uterus

Excludes Type 1

  • puerperal hypertrophy of uterus (O90.89)

Medical Intelligence & Overview

Hypertrophy of the uterus, also known as an enlarged or bulky uterus, is a condition where the uterus increases in size due to the growth of its tissue components. This enlargement can be caused by various benign causes, such as fibroids or other growths, and may impact a woman's health and reproductive functions. Recognizing the signs, causes, and potential treatments helps in managing this condition effectively.

Causes & Symptoms

Clinical Causes: Uterine fibroids (leiomyomas): Noncancerous growths arising from the muscle tissue of the uterus. Adenomyosis: A condition where endometrial tissue exists within the muscular wall of the uterus, causing swelling and enlargement. Pregnancy: The natural growth of the uterus during gestation leads to significant enlargement. Uterine polyps: Growths from the lining of the uterus which can contribute to increased size. Chronic inflammation or infection affecting the uterus. Hormonal imbalances, particularly those involving estrogen and progesterone. Rare benign tumors or other growth conditions of the uterine tissue.

Key Symptoms: Pelvic pain or pressure sensation. Heavy or prolonged menstrual bleeding. Pelvic or lower abdominal discomfort. Frequent urination or difficulty emptying the bladder. Feeling of fullness or heaviness in the pelvic region. Back pain or leg discomfort in some cases. Asymptomatic in some women, with enlargement found incidentally during examinations.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and imaging studies. A healthcare provider may perform a pelvic exam to assess uterine size and shape. Imaging techniques such as ultrasound are commonly used to visualize the uterus and determine the extent of hypertrophy. In certain cases, MRI or other advanced imaging may be necessary for detailed evaluation. Endometrial sampling or biopsy might be performed if abnormal bleeding or other concerns are present.

Treatment Protocols: Management of uterine hypertrophy depends on the underlying cause, the severity of symptoms, and a woman's reproductive plans. Treatment options include: - **Observation:** Monitoring if the enlargement causes no symptoms or issues. - **Medications:** Hormonal therapies, such as gonadotropin-releasing hormone (GnRH) agonists, may be used to reduce size or manage symptoms. - **Surgical options:** Procedures like myomectomy (removal of fibroids), hysterectomy (removal of the uterus), or endometrial ablation can be considered based on individual needs. - **Minimally invasive techniques:** Uterine artery embolization or focused ultrasound therapy may be used for fibroids. Consulting a healthcare professional is crucial for a tailored treatment plan that best suits the condition's specifics and the patient's health and reproductive goals.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N85.2 a billable ICD-10 code?
Yes, N85.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N85.2?
Clinical documentation must specify the nature of Hypertrophy of uterus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

uterus hypertrophy